Home Human language LDH now operates 6 monoclonal antibody therapy sites

LDH now operates 6 monoclonal antibody therapy sites

5
0

Baton Rouge, Louisiana (September 17, 2021) – The Louisiana Department of Health now operates six federally supported monoclonal antibody (mAb) therapy treatment sites and is on track to open seven additional sites until the end of next week.

Each site will be open 7 days a week from 8 a.m. to 6 p.m. with the capacity to serve more than 150 patients per day per site.

These are not walk-in sites; your health care provider should schedule your appointment.

AcM sites funded by the federal government and operational since September 17 are:

Large lots: 404 N. Canal St., Thibodaux, LA 70301
Burton Coliseum: 7001 Gulf Hwy., Lake Charles, LA 70607
Byrd Regional Hospital in Deer Creek: 810 S. 10th St., Leesville, LA 71496
Clinton Alternative Learning Center: 9414 Plank Road, Clinton, LA 70722
Rayne Civic Center: 400 Frog Festival Drive, Rayne, LA 70578
Coliseum of the Rapids car park: 5600 Coliseum Blvd., Alexandria, LA 71303

The dates and locations of additional sites scheduled to open include:

Saturday, September 18
State farm building: 24 Accent Drive, Monroe, LA 71203

Monday, September 20
Blackham Coliseum: 2330 Johnston Street, Lafayette, LA 70503
Houma Municipal Community Center: 880, rue Verret, Houma, LA 70360
Louisiana Fairgrounds: 3701 Hudson Ave, Shreveport, LA 71109
Moorehouse General Hospital: 323 W. Walnut Ave., Bastrop, LA 71220

Thursday 23 September
DeQuincy ball courts: 97 Bond Road, DeQuincy, LA 70633

saturday 25 september
1316 A 6, Campti, LA 71411

Louisiana received its first allocation of monoclonal antibodies on November 12, 2020 and began administering immediately to positive and symptomatic patients.

In addition to the federally supported sites, there are 143 providers statewide who have received shipments of mAb that they could administer as treatment.

Monoclonal antibodies are artificial antibodies produced in the laboratory that can mimic the response of the human immune system to infection. MAbs are designed to block viral uptake and entry into human cells, thereby neutralizing the virus that causes COVID-19.

Patients should be referred by their doctor or other healthcare professional at a facility that offers mAb therapy such as a hospital or infusion center. Those who do not have a provider may be referred by an emergency care department, community clinic, emergency department, hospital, etc.

Patients with a positive COVID-19 viral test should speak with their healthcare provider to determine if they are eligible for mAb treatment and to discuss potential benefits and side effects.

Monoclonal antibody treatments can be used for the treatment of mild to moderate COVID-19 in adults and pediatric patients who are within 10 days of the onset of their symptoms, at least 12 years of age or older and weighing at least less 40 kilograms (88 pounds) and are at high risk of progressing to severe COVID-19 and / or hospitalization.

The federal government has developed a searchable national map that shows the locations that have received shipments of therapeutic monoclonal antibodies under the authority of the US FDA in recent weeks. The scalable map can be found at https://protect-public.hhs.gov/pages/therapeutics-distribution.

A call center is available to answer questions and provide information about mAb Therapeutic Treatments at 1-877-332-6585 (in English) or 1-877-366-0310 (in Spanish).

Eligibility criteria

To be eligible for treatment with mAb, the patient must meet all of the following conditions:

Test positive for SARS-CoV-2 (molecular / PCR or antigen)
Are within 10 days of onset of symptoms
are at least 12 years of age or older and weigh at least 40 kilograms (88 pounds)
Are at high risk of progressing to severe COVID-19 and / or hospitalization

Patients are reminded that the procedure takes at least two hours. This includes 30 minutes to receive the infusion, followed by 1.5 hours of observation.

For patients who are taking medication, they should take their regular doses before treatment. It is also acceptable to eat before treatment.

For more information on mAbs, visit This site.

————————————————– ———-
Keep in touch with us anytime, anywhere.

To join the newsroom or report a typo / correction, click HERE.

Sign up for newsletters sent by email to your inbox. Choose from these options: Latest News, Evening News Headlines, Latest COVID-19 Headlines, Morning News Headlines, Special Offers

Follow us on twitter

Like us on facebook

Follow us on Instagram

Subscribe to our Youtube channel



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here